IPHA names Janssen's Dr Leisha Daly as president

Janssen's country director for Ireland Dr Leisha Daly has been elected as president of the Irish Pharmaceutical Healthcare Association (IPHA).

The role will see Daly, who has served as the Irish pharma association's vice president since 2012, represent the research-based pharma industry in Ireland.

Commenting on her election, Daly said: “As the new IPHA president, I will endeavour to working partnership with all relevant groups to ensure that patients in Ireland have access to optimal healthcare solutions.

“I believe that continued dialogue with the HSE and the Department of Health is critical to achieve our common goal - the health of Irish patients. Our doors remain open for collaboration and partnership and I am looking forward to us continuing this work in the interest of Irish patients over the next two years.”

Daly, who has also been a member of IPHA's board of directors since June 2012, was reappointed to the Association's Prescription Medicines Division Strategy Board in August 2012.

She joined Janssen as head of technical affairs in 1998 and since then has served in a variety of senior positions in medical, sales and marketing. Daly is also a member of the Janssen UK board of directors.